DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY
WARD, Keith W, STELMAN, Gary J, MORGAN, Jayme A, ZEIGLER, Kelli S, AZZARANO, Leonard M, KEHLER, Jonathan R, MCSURDY-FREED, Jeanelle E, PROKSCH, Joel W, SMITH, Brian R
Published in Drug metabolism and disposition (01.02.2004)
Published in Drug metabolism and disposition (01.02.2004)
Get full text
Journal Article
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
Billiard, Julia, Dennison, Jennifer B, Briand, Jacques, Annan, Roland S, Chai, Deping, Colón, Mariela, Dodson, Christopher S, Gilbert, Seth A, Greshock, Joel, Jing, Junping, Lu, Hong, McSurdy-Freed, Jeanelle E, Orband-Miller, Lisa A, Mills, Gordon B, Quinn, Chad J, Schneck, Jessica L, Scott, Gilbert F, Shaw, Anthony N, Waitt, Gregory M, Wooster, Richard F, Duffy, Kevin J
Published in Cancer & metabolism (06.09.2013)
Published in Cancer & metabolism (06.09.2013)
Get full text
Journal Article
SB-239063, a potent and selective inhibitor of p38 map kinase : Preclinical pharmacokinetics and species-specific reversible isomerization
WARD, Keith W, PROKSCH, Joel W, AZZARANO, Leonard M, SALYERS, Kevin L, MCSURDY-FREED, Jeanelle E, MOLNAR, Tina M, LEVY, Mark A, SMITH, Brian R
Published in Pharmaceutical research (01.09.2001)
Published in Pharmaceutical research (01.09.2001)
Get full text
Journal Article